Bone marrow transplant specialist Dr Gaurav Kharya "

Dr. Gaurav Kharya: Revolutionary Advances in Bone Marrow Transplantation and Sickle Cell Disease Treatment

Leading India's Breakthrough in Haploidentical Transplants

Dr. Gaurav Kharya stands at the forefront of bone marrow transplantation in India, revolutionizing treatment protocols for sickle cell disease (SCD) and other hematological disorders. As the Clinical Lead at Apollo Hospitals' Center for Bone Marrow Transplant and Cellular Therapy in New Delhi, his innovative approaches have transformed the landscape of pediatric hematology-oncology care.

Pioneering Achievements in Bone Marrow Transplantation

Performed nearly 1,000 transplants over seven years

Successfully completed over 100 sickle cell disease transplants

Developed groundbreaking protocols for haploidentical transplants

Holds India's record for successful SCD bone marrow transplants

Expertise and Specializations

Dr. Kharya's comprehensive medical expertise spans multiple critical areas:

Pediatric Hematology

Oncology

Immunology

Bone Marrow Transplantation

Cell and Gene Therapy

CAR T-cell therapy

Virus-specific T-cell treatments

Educational Background and Professional Journey

Dr. Kharya's distinguished career path includes:

1. MBBS from Netaji Subash Chandra Bose Medical College, Jabalpur

2. DCH in Pediatrics from Baba Raghav Das Medical College, Gorakhpur

3. DNB in Pediatrics from Sir Ganga Ram Hospital, Delhi

4. International Fellowships:

   Pediatric Hematology Oncology Immunology & BMT (SGRH, New Delhi)

   Pediatric Hematology Oncology Immunology & BMT (GNCH, UK)

   Pediatric Hematology & BMT (Imperial College, London)

Revolutionary Contributions to Medical Science

Haploidentical Transplant Innovation

Dr. Kharya's research has established haploidentical transplant as the preferred treatment option when perfect donor matches are unavailable. This breakthrough has significantly expanded treatment accessibility for patients with:

Sickle Cell Disease

Thalassemia

Leukemia

Other blood disorders

Future-Forward Medical Developments

As Founder and Director of Collagen Therapeutics, Dr. Kharya leads initiatives in:

Development of India-specific cell therapy products

Advanced gene therapy solutions

Innovative cancer treatment protocols

Cutting-edge immunological therapies

Making Advanced Treatment Accessible

Since returning to India in 2014, Dr. Kharya has focused on:

Reducing bone marrow transplant costs

Improving treatment accessibility

Developing affordable treatment protocols

Expanding cure options for blood disorders

Current Positions and Ongoing Work

Clinical Lead, Center for Bone Marrow Transplant and Cellular Therapy, Apollo Hospitals

Senior Consultant, Pediatric Hematology Oncology and Immunology

Founder and Director, Cellogen Therapeutics

Active researcher in cell and gene therapy development

Research and Innovation Focus

Dr. Kharya continues to advance medical science through:

 Publications on pediatric cancer treatment

 Development of cellular therapy products

 Research in virus-specific T-cell applications

 Innovation in CAR T-cell therapy protocols

Professional Schedule

Available for consultations Monday through Saturday at Apollo Hospitals, New Delhi.

Dr. Gaurav Kharya's groundbreaking work in bone marrow transplantation and hematological disorders has established new standards in pediatric care. His commitment to making advanced treatments more accessible continues to transform lives across India and beyond.